Caspase 7: The Executioner of Apoptosis | Community Health

Caspase 7, a cysteine-aspartic protease, plays a crucial role in the execution phase of apoptosis, a process of programmed cell death. Discovered in 1996 by a team of researchers led by Dr. Donald Nicholson, caspase 7 is one of the key executioner caspases, along with caspase 3 and caspase 6. With a Vibe score of 8, caspase 7 has been extensively studied for its involvement in various cellular processes, including apoptosis, inflammation, and cell differentiation. The controversy surrounding caspase 7's role in cancer development and treatment has sparked intense debate, with some researchers arguing that it promotes tumor growth, while others claim it has anti-tumor properties. As research continues to uncover the complexities of caspase 7's function, its potential as a therapeutic target remains a topic of interest. With over 1,500 research articles published on the topic, caspase 7's influence flow can be seen in the work of prominent researchers such as Dr. Guy Salvesen and Dr. Philip Cohen, who have significantly contributed to our understanding of its mechanisms and functions.